Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05823142 · ClinicalTrials.gov registry record · NA
Health Behavior Intervention for Adults With Type 1 Diabetes
A NA study of Type1diabetes, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT05823142 is a NA study of Type1diabetes that is actively recruiting participants, run by Emory University. The registered enrollment target is 300 participants, above the 246-participant average among 19 other Type1diabetes trials with a reported enrollment target (22% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05823142, a NA study of Type1diabetes, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
Type 1 diabetes (T1D) affects approximately 2 million Americans, and only 2 in 8 young adults ages 18-31 years achieve glycemic targets (glycated hemoglobin A1C \<7.0%). Achieving glycemic targets is associated with reduced risk of micro-and macrovascular complications. Sleep deprivation leads to impaired glucose tolerance and insulin sensitivity in adults without chronic conditions and with T1D. Promoting sleep in laboratory and natural environments contributes to improvements in insulin sensitivity, glucose levels, and distress symptoms in young adults without chronic conditions and more time in range in adolescents with T1D. Multiple dimensions of sleep health (alertness, timing, efficiency, and sleep duration) are associated with better achievement of glycemic targets in adults with T1D. Therefore, sleep health dimensions are appropriate therapeutic targets to improve glucoregulation and other diabetes self-management outcomes in this population. Our primary objective is to evaluate the immediate and short-term effects of a 12-week CB-sleep intervention compared to enhanced usual care (time balanced attention control) on actigraphy- and self-report derived sleep health dimensions and diabetes self-management outcomes (glycemia and distress symptoms) over 9-months (Stage II of the NIH Model for Behavior Change, ORBIT phase III). CB-sleep is guided by principles and practices from motivational interviewing and the Transtheoretical Model of Behavior Change with interactive stage-matched sessions.
Conditions Studied
Interventions
- BEHAVIORAL CB Sleep
Study Locations (1)
Georgia
- Emory University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2023-12-20 |
| Est. Completion | 2028-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05823142
The ClinicalTrials.gov registry entry for NCT05823142 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 246-participant average among 19 other Type1diabetes trials with a reported enrollment target (22% higher). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type1diabetes appearing as the primary indexed condition, and to 1 intervention - of which CB Sleep is the first listed.
NCT05823142 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT05823142 about?
NCT05823142 is a clinical study titled "Health Behavior Intervention for Adults With Type 1 Diabetes". Type 1 diabetes (T1D) affects approximately 2 million Americans, and only 2 in 8 young adults ages 18-31 years achieve glycemic targets (glycated hemoglobin A1C \<7.0%). Achieving glycemic targets is associated with reduced risk of micro-and macrovascular complications. Sleep deprivation leads to im...
What is the current status of trial NCT05823142?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2023-12-20. Estimated completion is 2028-12.
What conditions does trial NCT05823142 study?
This clinical trial studies the following conditions: Type1diabetes.
What interventions are being tested in trial NCT05823142?
The interventions under investigation include: CB Sleep (BEHAVIORAL).
Who is sponsoring clinical trial NCT05823142?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05823142 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type1diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Fasting on Hypoglycemic Counterregulation in Type 1 Diabetes
RECRUITING · NA
-
Effects of Ketosis on Brain Function in Patients With T1DM
RECRUITING · NA
-
Very Low Carbohydrate Diets and Glucagon Response in T1DM
RECRUITING · NA
-
Type 1 Diabetes Management Using a Very Low Carbohydrate Versus Standard Diet
RECRUITING · NA
-
Type 1 Diabetes Education and Support Study
ACTIVE NOT RECRUITING · NA
-
The Monitoring Study
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.